LASAACI 2022 Fall Symposia
The Los Angeles Society of Allergy, Asthma and Clinical Immunology (LASAACI) is a CME educational meeting jointly provided by the American College of Allergy, Asthma and Immunology and the LASAACI. The 2022 program is a four-hour event with speakers covering the topics of EoE, AERD, MCAS. The LASAACI Faculty are experts in their field and will provide evidence-based, clinical topics that address major aspects of attendee’s practices and will provide attendees exposure to new content.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of American College of Allergy, Asthma & Immunolgy and Los Angeles Society of Allergy, Asthma and Clinical Immunology (LASAACI). The American College of Allergy, Asthma & Immunolgy is accredited by the ACCME to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 4 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity
Allied health professionals
Upon completion of this activity the participant should be able to:
- Describe potential benefits and risks of JAK inhibitors in atopic dermatitis
- Identify the key features for safe and successful implementation of OIT in the office-based setting
- Recognize the pathophysiology of airway epithelial inflammation
Saturday, September 24, 2022
7:45AM-8:20AM Registration, Exhibits & Coffee Break
8:20AM-8:30AM WELCOME AND INTRODUCTION
Dean Chiang, MD, President/Program Director
Session Moderator: Dean Chiang, MD
8:30AM-9:30AM Eosinophilic Esophagitis: Diagnosis, Treatment and Pathogenesis
Jonathan M. Spergel, MD, PhD
9:30AM-10:30AM The American College of Allergy, Asthma & Immunology sponsored lecture:
Advocacy and Regulatory Update
James M. Tracy, DO
10:30AM-11:30AM Buffet Brunch, Exhibits, Posters
11:30AM-12:30PM AERD: From Diagnosis to Management in the Biologic Era
Katharine M. Woessner, MD, FAAAAI
12:30PM-1:30PM Elevated Tryptase - now what?
Andrew A. White, MD, FAAAAI, FACAAI
Disclosure Policy and Disclosures
As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewer, and other individuals in a position to control or influence the content of an activity must disclose ALL financial relationships with any ineligible company. The ACCME defines an “ineligible company” (formerly commercial interest) as a company whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. (Examples of ineligible companies include: Advertising, marketing, or communication firms whose clients are ineligible companies; bio-medical startups that have begun a governmental regulatory approval process; compounding pharmacies that manufacture proprietary compounds; device manufacturers or distributors; diagnostic labs that sell proprietary products; growers, distributors, manufacturers or sellers of medical foods and dietary supplements; manufacturers of health-related wearable products; pharmaceutical companies or distributors; pharmacy benefit managers; reagent manufacturers or sellers). For more information, visit www.accme.org.
Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.
All identified relevant financial relationships have been mitigated.
Jonathan M. Spergel, MD, PhD - Speaker: Regeneron/Sanofi; Researcher: Regeneron/Sanofi|
Andrew A. White, MD, FAAAAI, FACAAI - Speaker: Blueprint
Katharine M. Woessner, MD, FAAAAI - Advisor: AstraZeneca, BioCryst, GSK; Speaker: AstraZeneca, GSK
Sonal Patel, MD - Speaker: Sanofi/Regeneron
Sheila M. Bonilla, MD - Researcher: GSK
Rita Kachru, MD - Researcher: Aimmune
Jonathan Corren, MD - Advisor: AstraZeneca, Regeneron, Sanofi; Independent Contractor: Novartis, Regeneron, Teva; Speaker: AstraZeneca, GSK, Novartis, Regeneron, Sanofi; Researcher: AstraZeneca
The following have no relevant financial relationships to disclose:
James M. Tracy, DO, FACAAI
Danica Schulte, MD
Dean Chiang, MD
Joseph Yusin, MD
Edward Hu, MD
Andrew K. Wong, MD
- 4.00 AMA PRA Category 1 Credit™
- 4.00 Attendance
- 4.00 CBRN